×
About 20,520 results

ALLMedicine™ Osteosarcoma Center

Research & Reviews  10,085 results

International Trends in Incidence of Osteosarcoma (1988 - 2012).
https://doi.org/10.1002/ijc.33673
International Journal of Cancer; Rojas GA, Hubbard AK et. al.

May 8th, 2021 - Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. The etiology of OS is largely unknown but may be informed by comparisons of incidence and trends between geographic regions. Using the Cancer Incidence in Five Co...

Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma ce...
https://doi.org/10.1111/nyas.14601
Annals of the New York Academy of Sciences; Muscella A, Stefàno E et. al.

May 7th, 2021 - Salvia clandestina L. is a wild perennial species present in the Salento area of Italy. Here, we examined the in vitro effects of an aqueous extract of S. clandestina L. on the MG-63 osteosarcoma cell line. The extract reduced osteosarcoma cell vi...

Retracted In vitro antitumor activity of the ethyl acetate extract Potentilla chinensis...
https://doi.org/10.3892/mmr.2021.12129
Molecular Medicine Reports; Wan G, Tao JG et. al.

May 6th, 2021 - Following the publication of the above paper, a concerned reader drew to the Editor's attention that several figures bore striking similarities to other papers that were published at around the same time written by different authors based in diffe...

Identification of a novel glycolysis-related gene signature for predicting the prognosi...
https://doi.org/10.18632/aging.202958
Aging Yang M, Ma X et. al.

May 6th, 2021 - Glycolysis ensures energy supply to cancer cells, thereby facilitating tumor progression. Here, we identified glycolysis-related genes that could predict the prognosis of patients with osteosarcoma. We examined 198 glycolysis-related genes that sh...

see more →

Guidelines  9 results

Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq?cid=eb_govdel

Aug 21st, 2019 - Osteosarcoma and malignant fibrous histiocytoma (MFH) of bone treatment depends on site, extent of disease, and grade. Treatment options include surgery, chemotherapy, radiation therapy, and targeted therapy. Get detailed treatment information for...

Triassic Cancer—Osteosarcoma in a 240-Million-Year-Old Stem-Turtle
https://jamanetwork.com/journals/jamaoncology/fullarticle/2723578
Hairdy,Y.,et al

Feb 6th, 2019 - Paleopathology, the study of ancient disease, is a vital way by which we understand the evolution of pathogens, immune systems, healing physiology, and ultimately the environment. Cancer research has focused on its prevalence in various organisms ...

NCCN Guidelines Insights: Bone Cancer, Version 2.2017
http://www.jnccn.org/content/15/2/155.full
Biermann, J.,et al

Jan 31st, 2017 - The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's g.

ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas.
https://doi.org/10.1093/annonc/mdu153
Annals of Oncology : Official Journal of the European Soc... Wilhelm M, Dirksen U et. al.

Jun 25th, 2014 - Teenagers and young adults (TYA) cancer contributes substantially to morbidity and mortality in a population with much to offer society. TYA place distinct challenges upon cancer care services, many reporting feeling marginalized and their needs n...

SEOM clinical guidelines for the treatment of osteosarcoma in adults-2013.
https://doi.org/10.1007/s12094-013-1087-0
Clinical & Translational Oncology : Official Publication ... Redondo A, Cruz J et. al.

Aug 2nd, 2013 - The diagnosis and treatment of osteosarcoma should be performed by an experienced multidisciplinary team. Considering it is a systemic disease, chemotherapy is essential for long-term success. The drugs most commonly used are: cisplatin, adriamyci...

see more →

Drugs  63 results see all →

Clinicaltrials.gov  10,259 results

International Trends in Incidence of Osteosarcoma (1988 - 2012).
https://doi.org/10.1002/ijc.33673
International Journal of Cancer; Rojas GA, Hubbard AK et. al.

May 8th, 2021 - Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. The etiology of OS is largely unknown but may be informed by comparisons of incidence and trends between geographic regions. Using the Cancer Incidence in Five Co...

Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma ce...
https://doi.org/10.1111/nyas.14601
Annals of the New York Academy of Sciences; Muscella A, Stefàno E et. al.

May 7th, 2021 - Salvia clandestina L. is a wild perennial species present in the Salento area of Italy. Here, we examined the in vitro effects of an aqueous extract of S. clandestina L. on the MG-63 osteosarcoma cell line. The extract reduced osteosarcoma cell vi...

Retracted In vitro antitumor activity of the ethyl acetate extract Potentilla chinensis...
https://doi.org/10.3892/mmr.2021.12129
Molecular Medicine Reports; Wan G, Tao JG et. al.

May 6th, 2021 - Following the publication of the above paper, a concerned reader drew to the Editor's attention that several figures bore striking similarities to other papers that were published at around the same time written by different authors based in diffe...

Identification of a novel glycolysis-related gene signature for predicting the prognosi...
https://doi.org/10.18632/aging.202958
Aging Yang M, Ma X et. al.

May 6th, 2021 - Glycolysis ensures energy supply to cancer cells, thereby facilitating tumor progression. Here, we identified glycolysis-related genes that could predict the prognosis of patients with osteosarcoma. We examined 198 glycolysis-related genes that sh...

see more →

News  83 results

Tumor Profiling Yields Insights Into Poor Osteosarcoma Response to Immunotherapy
https://www.medscape.com/viewarticle/926055

Mar 2nd, 2020 - NEW YORK (Reuters Health) - Multiple genetic and cellular factors contribute to osteosarcoma's poor response to immunotherapy, researchers say. "Despite its genomic complexity, treatment with immune checkpoint inhibitors has been ineffective for p...

Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq?cid=eb_govdel

Aug 21st, 2019 - Osteosarcoma and malignant fibrous histiocytoma (MFH) of bone treatment depends on site, extent of disease, and grade. Treatment options include surgery, chemotherapy, radiation therapy, and targeted therapy. Get detailed treatment information for...

From the journals: sarcoma around the world
https://www.mdedge.com/sarcomajournal/article/203054/sarcoma/journals-sarcoma-around-world/page/0/2?channel=50183

Jun 17th, 2019 - PEDIATRIC OSTEOSARCOMA IN LEBANON: Investigators at a single institution in Lebanon reported a similar survival rate for newly diagnosed patients with pediatric osteosarcoma treated at their center as for those treated in more developed countries.

Wolf in sheep’s clothing: metatarsal osteosarcoma
https://www.mdedge.com/sarcomajournal/article/203028/osteosarcoma/wolf-sheeps-clothing-metatarsal-osteosarcoma/page/0/2?channel=47427

Jun 17th, 2019 - Conclusions Osteosarcoma of the metatarsal is rare. Our case remains unique as it reports the second youngest patient in the literature.

An unusual presentation of low-grade clavicle osteosarcoma: a case report and literature review
https://www.mdedge.com/sarcomajournal/article/203016/osteosarcoma/unusual-presentation-low-grade-clavicle-osteosarcoma-case/page/0/2?channel=47427

Jun 17th, 2019 - Radiographs can be misleading as well. Prior studies have demonstrated that low-grade central OS can be readily misdiagnosed as fibrous dysplasia, desmoplastic fibroma, nonossifying fibroma, osteoblastoma, and aneurysmal bone cyst.

see more →

Patient Education  21 results see all →